175 results
8-K
CHRS
Coherus Biosciences Inc
5 Jun 24
Departure of Directors or Certain Officers
9:11am
appointed to serve on the Audit Committee of the Board.
Ms. Karachun, age 61, served at Merck & Co., Inc. as SVP and Global Controller from March 2014 … to receive an annual cash retainer for service on the Board and the Audit Committee in the amount of $60,000. On June 4, 2024, Ms. Karachun received
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or requirements of any applicable U.S. national securities exchange applicable to the Seller or any of its Equity Interests.
“Audit Arbitrator … , the Buyer may cause an inspection and/or audit, by an independent public accounting firm reasonably acceptable to the Seller and subject to a confidentiality
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
of unaudited, interim financial statements, subject to normal year-end audit adjustments and the exclusion of certain footnotes, and any supporting schedules … discretion of the Collateral Agent) audit any Credit Party’s Books. The foregoing inspections and audits, if any, shall be at the relevant Credit Party’s
DEFA14A
y3wmtl7
15 Apr 24
Additional proxy soliciting materials
5:10pm
8-K
n39l4
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
ecuceoth5z6walxg
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am